Presentation Topics:
- Review of the general management of opioid withdrawal
- Addressing the challenges posed by the Fentanyl/ Xylazine era
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and the Society of Hospital Medicine Delaware Chapter. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of Delaware designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of the Medical Society of Delaware to comply with the ACCME Standards for Commercial Support of Continuing Medical Education. In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.
Joint providership of CME by MSD in no way implies endorsement of any product or service.
This activity is supported by an educational grant from the Health Resources and Services Administration (HRSA).
Please Click here to Register for the virtual meeting to receive the Zoom link.
To claim CME for this event, please click here to pre-register yourself through the Medical Society of Delaware's CME portal prior to the meeting.
Event Map
Event Comments